Mechanistically, an in vitro study using ovarian cancer cells demonstrated that RAD51AP1 promoted the progression of ovarian cancer via the TGF‐β/Smad signaling pathway (Zhao et al. 2021). This evidence concerns the gene RAD51AP1 and ovarian carcinoma.